DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Vaccination for 12-14 age group likely from March, says top govt expert

  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

New Delhi, Jan 17

Advertisement

India may begin inoculating children in the 12-14 age group against COVID-19 in March as the 15-18 population is likely to get fully vaccinated by then, Dr N K Arora, chairman of the COVID-19 working group of NTAGI, said on Monday.

Of the estimated 7.4 crore (7,40,57,000) population in the 15-18 age bracket, over 3.45 crore have received the first dose of Covaxin so far and their second dose is due in 28 days, he said.

Advertisement

“Adolescents in this age group have been actively participating in the inoculation process, and going by this pace of vaccination, the rest of the beneficiaries in the 15-18 age group are likely to be covered with the first dose by January-end and subsequently their second dose is expected to be done by February-end,” said the Chairman of the Covid working group of the National Technical Advisory Group on Immunisation (NTAGI).

Once the 15-18 age group is covered, he said, the government is likely to take a policy decision for initiating the vaccination drive for the 12-14 age group in March, he said.

According to him, there is an estimated 7.5 crore population in the 12-14 age group.

Advertisement

Provisional vaccination reports till 7 am on Monday showed that with more than 39 lakh doses being administered in a span of 24 hours, the cumulative number has exceeded 157.20 crore doses.

According to government data, over 3.45 crore first doses have been given to children in the 15-18 years age group so far.

India began administering the “precaution dose” — a third jab of COVID-19 vaccine — to healthcare, frontline workers including personnel deployed for election duty and those aged 60 and above with comorbidities from January 10 amid the country witnessing a spike in coronavirus infections, driven mainly by the Omicron variant of the virus.

Advertisement
Advertisement
Advertisement
tlbr_img1 Classifieds tlbr_img2 Videos tlbr_img3 Premium tlbr_img4 E-Paper tlbr_img5 Shorts